2020
DOI: 10.1016/j.idcr.2020.e00965
|View full text |Cite
|
Sign up to set email alerts
|

Disseminated tuberculosis confounding a co-morbid primary CNS lymphoma

Abstract: Primary central nervous system lymphoma is notoriously challenging to diagnose in immunocompetent patients as it is an uncommon diagnosis. We present a case of synchronous diagnosis with tuberculosis. A 60-year-old woman presented with cognitive difficulties, memory loss, social withdrawal, unintentional weight loss, and night sweats, the work-up of which ultimately identified multiple brain lesions and mediastinal adenopathy. Brain biopsy showed lymphohistiocytic infiltrate, while mediastinal node histopathol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 6 publications
(6 reference statements)
0
1
0
Order By: Relevance
“…Although most recent studies have focused on distinguishing between TBM and meningitis of other bacterial or infectious origins, an early 1990s study already reported that the concentration of CSF-ADA could be elevated in patients with lymphoma (5 patients, range, 4–25 IU/L) like in TBM (3 patients, range, 20–23 IU/L) ( Pettersson et al., 1991 ). Lymphoma and TBM are representative diseases whose clinical manifestations can mimic each others'’, or the two can exist concomitantly ( Falagas et al., 2010 ; Tai et al., 2020 ). In these circumstances, CSF-ADA is not a very useful diagnostic parameter, and clinicians usually experience more trouble in distinguishing between TBM and HM, than between TBM and bacterial meningitis.…”
Section: Discussionmentioning
confidence: 99%
“…Although most recent studies have focused on distinguishing between TBM and meningitis of other bacterial or infectious origins, an early 1990s study already reported that the concentration of CSF-ADA could be elevated in patients with lymphoma (5 patients, range, 4–25 IU/L) like in TBM (3 patients, range, 20–23 IU/L) ( Pettersson et al., 1991 ). Lymphoma and TBM are representative diseases whose clinical manifestations can mimic each others'’, or the two can exist concomitantly ( Falagas et al., 2010 ; Tai et al., 2020 ). In these circumstances, CSF-ADA is not a very useful diagnostic parameter, and clinicians usually experience more trouble in distinguishing between TBM and HM, than between TBM and bacterial meningitis.…”
Section: Discussionmentioning
confidence: 99%